Review credibility
- Publisher
- FinReview Mark
- Author
- FinReview Mark Research Team
- First published
- 2026-06-10
- Last verified
- 2026-06-10
This page is an independent FinReview Mark review. FinReview Mark is not affiliated with the reviewed company and does not provide investment advice. Scores shown above are editorial assessments unless labeled as user reviews.
Basic Information
Company Rating & Analysis
Summary
Catalyst Crew Technologies Corp. (brand name LATAMED AI) publicly states it is a medical artificial intelligence technology company listed on the US OTC market (ticker LMED), focusing on developing AI-driven medical analytics platforms and telehealth infrastructure for the Latin American market. However, current public information reveals multiple high-risk signals: the official website domain was registered approximately 92 days ago, core AI modules are all under development with no regulatory approvals, corporate governance is centralized under a single director/officer, and the regulatory claims self-reported on the website cannot be verified in the public databases of major regulators such as the US and UAE. The comprehensive score is 17/100, indicating extremely high risk. Before a full verification of company registration, operating entity, license qualifications, and fund security, investors are strongly advised to proceed with caution and must not deposit or invest funds blindly.
Institution Overview
| Item | Content |
|---|---|
| Brand Name | Catalyst Crew / LATAMED AI |
| Official Website | https://catalystcrewai.com/ |
| Claimed Entity | Catalyst Crew Technologies Corp. (OTC ticker LMED) |
| Operating Subsidiary | LataMed AI Corp. |
| Self-claimed Business Type | Medical AI analytics platform, telemedicine infrastructure, coordinated care system |
| Claimed Registered Address | 30 North Gould Street, Suite R Sheridan, WY 82801 (Wyoming, USA) |
| Contact Email | ir@catalystcrewai.com, info@cataystcrewai.com (typo on website) |
| Contact Phone | +1 (787) 476-2350 |
| Domain Registration Date | 2026-03-02 |
| Risk Assessment | Extremely High Risk (Comprehensive Score 17/100) |
Company Entity and Registration Documents
Public Company Records
According to information disclosed on the website and retrieved from public registration data, the following entities are associated with Catalyst Crew:
- Catalyst Crew Technologies Corp.: Claimed to be listed on OTC Markets (ticker LMED) and subject to SEC reporting requirements. The SEC EDGAR system shows an associated entity, LataMed AI Corp. (CIK No. 0001477960), indicating that the company has previously filed SEC documents. However, this record only confirms the existence of a corporate file and does not constitute verification of current operating status or license.
- CATALYST CREW LIMITED: Registered at Companies House in the UK, registration number 16297212, address 329 Eastern Avenue, Ilford, England, IG2 6NT, registration date 2025-03-06. Whether this entity is the same operating entity as the US company claimed on catalystcrewai.com requires further verification.
- VStock Transfer, LLC: The stock transfer agent mentioned on the website is a third-party service provider and not a registered entity.
Note: The UK company "CATALYST CREW LIMITED" differs from the US OTC company entity claimed on the website, suggesting potential cross-border structural ambiguity.
Company Registration Verification Summary
- US Wyoming Business Registration: Current public materials have not directly completed a formal query of the Wyoming Secretary of State database; the company's registration status cannot be confirmed from official channels.
- UK Company Record: An independent entity CATALYST CREW LIMITED exists, but the website does not explicitly identify it as the operating entity.
- Canada Federal Corporation Search: No matching records found.
- Hong Kong Companies Registry: No automated query completed.
Conclusion: Multiple entities exist across borders, but the completeness and consistency of official registration records have not been fully verified.
Regulatory and License Status
Analysis of Regulatory Statements on the Website
The website explicitly states: "The Company has not obtained regulatory clearance for diagnostic claims associated with its AI modules and has not commenced commercial healthcare operations."
Additionally, the website states that "LATAMED AI operates in the highly regulated healthcare and digital technology sectors" and commits to complying with SEC reporting requirements. However, it does not provide any financial services license or specific regulatory registration number.
Results of Queries to External Regulatory Databases
| Regulator/Database | Query Result | Explanation |
|---|---|---|
| US SEC (EDGAR) | Record found for LataMed AI Corp. | Only confirms company has filed documents; does not constitute an operating license or permit |
| US FinCEN (MSB) | No matching record | Not registered as a money services business |
| US NFA (Futures Association) | No matching record | No futures or derivatives related qualifications |
| UAE SCA (Securities and Commodities Authority) | No matching record | The regulatory code "rmalization" claimed on the website cannot correspond to any valid license |
| UK FCA (Financial Conduct Authority) | No automated query completed | Manual verification needed |
Regulatory Summary
- No valid financial trading license: The platform does not provide any regulatory license related to forex, CFDs, securities brokerage, or digital currency trading.
- Medical diagnostic claims not approved: The website itself acknowledges that the AI modules have not been approved by any pharmaceutical regulatory body.
- Self-claimed "UAE SCA/CMA" statement cannot be verified: The website's AI technology architecture page contains the phrase "UAE SCA/CMA rmalization." A query of the UAE SCA public license list yields no matching record. This statement is likely a typographical error or an invalid reference.
Conclusion: Based on currently available public information, catalystcrewai.com cannot be confirmed to hold any valid and effective operating license for financial services or medical diagnostics. Investors should be highly vigilant about the risk of unlicensed operations.
Website, Domain, Address, and Contact Information
Domain Information
| Item | Content |
|---|---|
| Domain | catalystcrewai.com |
| Registration Date | 2026-03-02 |
| Expiration Date | 2028-03-02 |
| Registrar | HOSTINGER operations, UAB |
| Domain Age | Approximately 92 days (as of assessment date) |
High-Risk Signal: Domain registration less than 1 year (only 92 days), a common characteristic of high-risk short-term websites. Newly registered domains are often used for temporary operational websites and require close attention.
Address Information
Self-reported addresses on the website:
- Sheridan, Wyoming, USA: 30 North Gould Street, Suite R Sheridan, WY 82801
- Caracas, Venezuela: AV Romulo Gallegos Con Avenida Las Palmas, Edif Torre Gerencial Los Andes, Piso 4 Oficina 4-D, Urb Boleita, Caracas, Miranda, Zona Postal 1071
Address Verification Note: The above addresses are self-disclosed on the website. Current public materials have not confirmed the correspondence of the "Catalyst Crew" or "LataMed AI" brand to these addresses via Google Maps or other public mapping/registration platforms. Address authenticity requires manual verification.
Contact Information
- Email: ir@catalystcrewai.com (Investor Relations) / info@cataystcrewai.com (Note: this email is missing the letter "l"; correct should be catalyst)
- Phone: +1 (787) 476-2350 (Puerto Rico area code)
- Contact Form: The /contact page on the website provides an online form
Risk Point: Contact email contains a typo (catayst instead of catalyst), which may affect communication reliability.
Products and Services
According to the website content, Catalyst Crew (LATAMED AI) claims to offer the following products and services:
- CardioAI™: Cardiovascular risk and imaging analysis (under development)
- PulmoAI™: Pulmonary function risk and respiratory analysis (under development)
- NeuroAI™: Neurological analysis (under development)
- Telemedicine Infrastructure: Encrypted virtual consultations, digital patient workflow
- Hybrid Care Coordination Framework: Community-based home healthcare service coordination
Important Statement: The website explicitly states that all AI modules are under development and have not obtained any regulatory approval or completed clinical validation. The company has also not commenced commercial healthcare operations. These products are currently only descriptions of "proposed capabilities" and do not constitute actual commercially available services.
Public Footprint and Negative Information
Public Search Results
Searches across multiple search engines using keywords such as "catalystcrewai.com", "Catalyst Crew", "scam", "complaint", "withdrawal problem" did not yield direct fraud complaints, withdrawal difficulty reports, or regulatory warning pages.
Negative Source Excerpts (Require Manual Verification)
As of the assessment date, public searches did not return explicit negative information regarding catalystcrewai.com. However, it should be noted:
- This brand has been operating for an extremely short time (domain only 92 days, UK company registered approximately 1 year), and public exposure is low. Therefore, the absence of negative results does not equate to safety.
- The website content primarily focuses on investor relations (emphasizing OTC ticker LMED), potentially indicating a focus on capital raising rather than actual business operations.
Summary of Negative Risk Signals
| Signal | Severity | Explanation |
|---|---|---|
| Newly Registered Domain | High | Registered less than 1 year |
| No Valid Regulatory License | High | Both medical and financial licenses unverifiable |
| Single Governance Structure | Medium | Website shows only 1 director and 1 officer holding multiple positions |
| Cross-border Address Ambiguity | Medium | Simultaneous addresses in Wyoming, USA and Caracas, Venezuela |
| Contact Information Flaw | Low | Official email contains typo |
| Negative Public Records | Not Found | No public complaints or warnings currently, but this cannot be taken as a guarantee of safety |
Comprehensive Evaluation
Score Breakdown
| Dimension | Score | Explanation |
|---|---|---|
| Company Entity Verification | Medium | EDGAR has file, UK has registered entity, but full status not directly confirmed |
| Regulatory License Verification | 0 | No valid financial services or medical license verifiable |
| Domain Credibility | Low | Registered only 92 days, high-risk new domain |
| Address and Map Verification | 0 | Addresses self-reported only, no correspondence confirmed via public maps or registries |
| Negative Information Screening | Not Found | No public complaints, but brand exposure is minimal |
| Risk Additional Deduction | -18 | Due to high-risk signals (new domain, no license, governance risks, etc.) |
| Total Score | 17/100 | Extremely High Risk |
Comprehensive Judgment
Catalyst Crew (catalystcrewai.com) claims to operate a medical AI platform and be publicly traded on the OTC market, but currently available public information is insufficient to support its legitimacy and safety:
- No Valid Regulatory License: All self-reported regulatory statements cannot be verified in official databases. The medical AI modules have not been approved by any national drug or medical device regulatory authority.
- Extremely High Domain Risk: The website has been online for only 3 months, a typical characteristic of short-term operational websites.
- Opaque Company Structure: Multiple cross-border entities exist, and the ownership of the core operating entity is ambiguous.
- Unverifiable Business Status: Core products are all under development with no commercial operating record. Website content focuses on investor relations.
Strongly Recommended: Do not provide personal information or invest any funds on this platform until the following verifications are completed:
- Confirm the current status of Catalyst Crew Technologies Corp. via the Wyoming Secretary of State
- Review its latest periodic reports and financial statements via SEC EDGAR
- Confirm the current trading status and shareholder information of its OTC ticker LMED
- Verify whether all addresses correspond to actual operational business premises
- Contact relevant medical regulatory authorities to confirm whether it has the right to provide diagnostic services
Public Source Links
The following links are public entry points referenced in this review, allowing readers to verify independently:
- Official Website
- RDAP domain lookup: catalystcrewai.com
- US State Business Registry public-page crawl
- SEC EDGAR Company Search public-page crawl
- Public Record
- Companies House public-page crawl
- Public Record
- Hong Kong Companies Registry public-page crawl
- Regulatory lookup route: UAE SCA/CMA rmalization
- Corporations Canada public-page crawl
- SEC RIA/IAPD, EDGAR and Form D official lookup
- FinCEN MSB public-page crawl
Frequently Asked Questions
What is Catalyst Crew? Is it a provider of forex, CFDs, stocks, precious metals, energy, cryptocurrencies, or other investment trading services?
Catalyst Crew (brand name LATAMED AI) describes itself on its website as a medical artificial intelligence technology company focused on developing AI-driven medical analytics platforms, telemedicine infrastructure, and coordinated care systems. Its stock is publicly quoted on OTC Markets under the ticker LMED. This platform is not a traditional forex, CFD, precious metals, or cryptocurrency trading service provider, but its publicly traded stock nature involves it in securities investment. It should be noted that its core AI products are stated to be under development, have not obtained any regulatory approval, and have not commenced commercial operations.
What trading products, account services, trading software, platform website functions, or financial services does Catalyst Crew offer?
According to the website information, Catalyst Crew does not provide actual execution services for forex, stocks, CFDs, or cryptocurrencies. Its claimed products are primarily three disease-specific AI analysis modules (CardioAI, PulmoAI, NeuroAI), along with telemedicine infrastructure and a hybrid care coordination framework. The website includes investor relations pages, stock information pages, and a contact form. Overall, the platform appears more like an early-stage medical technology concept company rather than a mature financial service provider.
Can Catalyst Crew's website, company entity, registered address, customer service email, contact information, and public materials be verified?
Partially verifiable, but with many incompletenesses and inconsistencies:
- Website: catalystcrewai.com, domain registered only 92 days, high-risk new domain.
- Company Entity: SEC EDGAR records (LataMed AI Corp.) and UK Companies House records (CATALYST CREW LIMITED) can be found, but the Wyoming local registration has not been officially verified.
- Self-reported Addresses: The website self-reports two addresses: Sheridan, Wyoming and Caracas, Venezuela. Neither has a matching brand record found on public maps or registries.
- Contact Emails: Provides ir@catalystcrewai.com and info@cataystcrewai.com (the latter has a typo).
- Phone: +1 (787) 476-2350.
The above information requires further verification.
Is Catalyst Crew regulated? Does it have public licenses, registration numbers, regulatory bodies, financial service permits, or company search records?
Based on currently available public information, Catalyst Crew does not hold any valid financial trading service license or medical diagnostic regulatory permit. The self-reported "UAE SCA/CMA" statement on the website has no matching record in the public database of the UAE Securities and Commodities Authority. The company's EDGAR file with the US SEC only proves it has filed corporate documents; it does not constitute a trading license. Furthermore, queries to FinCEN and NFA in the US returned no matching results. Overall, it cannot be confirmed that the company holds any valid and effective operating license.
Before opening an account, depositing, trading, or submitting personal information with Catalyst Crew, what key information should investors focus on verifying?
Before taking any action, it is recommended to focus on verifying:
- Company Registration Status: Verify the current registration status and good standing certificate of Catalyst Crew Technologies Corp. via the official Wyoming Secretary of State database.
- SEC Filings: Review the latest annual report (10-K) and quarterly reports (10-Q) via EDGAR to understand the financial condition and actual business progress.
- Stock Trading Status: Confirm the current quote, trading volume, and any cautionary status of ticker LMED via the official OTC Markets channel.
- Address Authenticity: Confirm through on-site inspection or third-party verification services whether the two addresses correspond to actual business premises.
- License Qualifications: Contact the US FDA, US SEC, and any claimed regulatory bodies to verify its licensing situation.
Is Catalyst Crew a scam platform? Are there online materials related to scam, fraud, black platforms, investment fraud, or fake brokers?
As of the assessment date, public search engine searches have not found direct scam complaints, fraud reports, or black platform exposures specifically targeting catalystcrewai.com. However, the brand has been operating for an extremely short time (domain only 92 days), with very low public exposure. The absence of negative information does not equate to safety. Investors should not let down their guard due to the lack of negative records and must make a comprehensive judgment considering high-risk signals such as the new domain, lack of license, and opaque operations.
Is Catalyst Crew legitimate? Are its company registration, license claims, regulatory materials, and actual operating entity consistent?
Legitimacy is questionable. While company files exist at the SEC and UK Companies House, the following inconsistencies are present:
- The relationship between the US entity (Catalyst Crew Technologies Corp., claiming OTC listing) and the UK entity (CATALYST CREW LIMITED) is not clearly explained.
- The self-reported regulatory statements on the website (UAE SCA/CMA) cannot be verified, and the medical AI modules have not obtained any regulatory approval.
- The company's actual operating status is unclear – the website explicitly states it "has not commenced commercial healthcare operations."
- The domain registration date is later than some company registration dates (UK company registered in March 2025, domain registered in March 2026), and the timeline needs further clarification.
Is Catalyst Crew safe? What should be noted regarding fund security, account security, trading risks, personal data security, and platform credibility?
Based on currently available public information, this platform presents significant risks:
- Fund Security: If investors purchase its stock through the OTC market, fund risk derives from the company's operational condition; if the platform directly accepts investment funds, there is no third-party fund custody guarantee.
- Account and Personal Data Security: The website is built with WordPress. No professional security certifications or detailed privacy protection policies were found in public information.
- Trading Risk: If the platform ultimately fails to obtain medical device or financial services licenses, its business value could become zero.
- Platform Credibility: The new domain, typo in contact information, concentrated governance structure, and cross-border address ambiguity are all signals of questionable credibility.
Are there any complaints of withdrawal failure, inability to withdraw, withdrawal problems, difficulty withdrawing, refusal to pay out, or funds being unrecoverable against Catalyst Crew?
Currently, public searches have not found any withdrawal complaint records specifically targeting catalystcrewai.com. However, this platform is not a traditional trading or investment platform. If users remit funds directly to the company rather than buying and selling stocks through the public securities market, they may face the risk of funds being directly collected and difficult to recover. In the absence of clear withdrawal rules and third-party regulation, the risk of withdrawal issues cannot be ignored.
Are there any complaints, negative reviews, exposures, negative news, regulatory warnings, blacklist records, or high-risk public materials about Catalyst Crew?
As of now, public searches have not found this platform on official regulatory warning lists, financial blacklists, or negative records in mainstream media reports. However, based on a comprehensive assessment of signals including the new domain (92 days), lack of valid license, and unclear business prospects, this platform already falls into the high-risk category. Investors should continuously monitor its latest developments through public databases such as SEC EDGAR, OTC Markets official channels, and the Wyoming Secretary of State.
Source Statement
This review is based on the following public information sources. All analysis and conclusions are derived from a comprehensive assessment of these materials and do not constitute any form of legal or investment advice.
- Website Content: https://catalystcrewai.com/ (and its subpages)
- Domain Registration Record: RDAP Verisign query results
- SEC EDGAR: https://www.sec.gov/edgar/browse/?CIK=0001477960
- UK Companies House: https://find-and-update.company-information.service.gov.uk/company/16297212
- US FinCEN MSB Query: https://msb.fincen.gov
- US NFA BASIC Query: https://www.nfa.futures.org/BasicNet
- UAE SCA Public License List: https://www.sca.gov.ae/en/open-data/licensed-companies.aspx
- US State Business Registration Portal: https://www.usa.gov/state-business
- Google Maps Address Search (used as verification entry; brand matching not confirmed)
Disclaimer: This review is based solely on publicly available information as of the writing date. It does not guarantee the completeness or timeliness of the information. Regulatory status, company records, and search results may change at any time. Before making any decisions, investors should independently verify through the above official channels and consult professional legal or financial advisors.
User Reviews
Open this company’s topic page to write a post
Go comment